Zentalis Pharmaceuticals Becomes Oversold (ZNTL)
Dividend Channel Staff - Friday, April 26, 11:59 AM
Commit To Buy Zentalis Pharmaceuticals At $5, Earn 6.5% Annualized Using Options
Dividend Channel Staff - Friday, April 12, 11:33 AM
Analysts Predict 23% Upside For The Holdings of BIB
Dividend Channel Staff - Monday, February 12, 10:44 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $69.82 per unit. Read More »
Look Under The Hood: VB Has 10% Upside
Dividend Channel Staff - Friday, January 12, 6:26 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap ETF (VB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $229.62 per unit. Read More »
Notable Thursday Option Activity: CVX, ZNTL, TWLO
Dividend Channel Staff - Thursday, January 11, 3:18 PM
Analysts Predict 16% Gains Ahead For The Holdings of VBK
Dividend Channel Staff - Tuesday, December 12, 6:53 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap Growth ETF (VBK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $261.82 per unit. Read More »
Oversold Conditions For Zentalis Pharmaceuticals (ZNTL)
Dividend Channel Staff - Monday, November 27, 4:31 PM
Implied IWO Analyst Target Price: $294
Dividend Channel Staff - Thursday, November 9, 7:04 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Russell 2000 Growth ETF (IWO), we found that the implied analyst target price for the ETF based upon its underlying holdings is $294.45 per unit. Read More »
Noteworthy Tuesday Option Activity: BTU, ZNTL, AKAM
Dividend Channel Staff - Tuesday, November 7, 3:31 PM
Oversold Conditions For Zentalis Pharmaceuticals (ZNTL)
Dividend Channel Staff - Monday, November 6, 11:47 AM
Analysts Anticipate 22% Gains Ahead For VHT
Dividend Channel Staff - Tuesday, October 10, 6:40 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $289.92 per unit. Read More »
Commit To Buy Zentalis Pharmaceuticals At $15, Earn 17.9% Annualized Using Options
Dividend Channel Staff - Monday, October 9, 2:10 PM
Oversold Conditions For Zentalis Pharmaceuticals (ZNTL)
Dividend Channel Staff - Monday, September 18, 4:10 PM
Investors Pick Up ZNTL Even Cheaper Than Its Secondary Stock Offering
Dividend Channel Staff - Monday, September 18, 1:12 PM
Zentalis Pharmaceuticals (ZNTL) Shares Cross Below 200 DMA
Dividend Channel Staff - Monday, September 18, 11:36 AM
Analysts Anticipate 23% Upside For ESML
Dividend Channel Staff - Friday, September 8, 7:35 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares ESG Aware MSCI USA Small-Cap ETF (ESML), we found that the implied analyst target price for the ETF based upon its underlying holdings is $43.26 per unit. Read More »
Implied VBK Analyst Target Price: $270
Dividend Channel Staff - Tuesday, August 8, 10:47 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap Growth ETF (VBK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $269.70 per unit. Read More »
Commit To Purchase Zentalis Pharmaceuticals At $17.50, Earn 10.3% Annualized Using Options
Dividend Channel Staff - Monday, July 10, 1:40 PM
Sum Up The Parts: VBK Could Be Worth $263
Dividend Channel Staff - Wednesday, July 5, 6:19 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap Growth ETF (VBK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $262.65 per unit. Read More »
Analysts Expect VB Will Reach $224
Dividend Channel Staff - Wednesday, May 24, 6:44 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap ETF (VB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $224.34 per unit. Read More »
Notable Monday Option Activity: ZNTL, GOOG, MQ
Dividend Channel Staff - Monday, May 22, 3:32 PM
Thursday's ETF with Unusual Volume: IBBQ
Dividend Channel Staff - Thursday, July 8, 12:39 PM Read More »
Dividend Channel Staff - Friday, April 26, 11:59 AM
Commit To Buy Zentalis Pharmaceuticals At $5, Earn 6.5% Annualized Using Options
Dividend Channel Staff - Friday, April 12, 11:33 AM
Analysts Predict 23% Upside For The Holdings of BIB
Dividend Channel Staff - Monday, February 12, 10:44 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $69.82 per unit. Read More »
Look Under The Hood: VB Has 10% Upside
Dividend Channel Staff - Friday, January 12, 6:26 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap ETF (VB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $229.62 per unit. Read More »
Notable Thursday Option Activity: CVX, ZNTL, TWLO
Dividend Channel Staff - Thursday, January 11, 3:18 PM
Analysts Predict 16% Gains Ahead For The Holdings of VBK
Dividend Channel Staff - Tuesday, December 12, 6:53 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap Growth ETF (VBK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $261.82 per unit. Read More »
Oversold Conditions For Zentalis Pharmaceuticals (ZNTL)
Dividend Channel Staff - Monday, November 27, 4:31 PM
Implied IWO Analyst Target Price: $294
Dividend Channel Staff - Thursday, November 9, 7:04 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Russell 2000 Growth ETF (IWO), we found that the implied analyst target price for the ETF based upon its underlying holdings is $294.45 per unit. Read More »
Noteworthy Tuesday Option Activity: BTU, ZNTL, AKAM
Dividend Channel Staff - Tuesday, November 7, 3:31 PM
Oversold Conditions For Zentalis Pharmaceuticals (ZNTL)
Dividend Channel Staff - Monday, November 6, 11:47 AM
Analysts Anticipate 22% Gains Ahead For VHT
Dividend Channel Staff - Tuesday, October 10, 6:40 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $289.92 per unit. Read More »
Commit To Buy Zentalis Pharmaceuticals At $15, Earn 17.9% Annualized Using Options
Dividend Channel Staff - Monday, October 9, 2:10 PM
Oversold Conditions For Zentalis Pharmaceuticals (ZNTL)
Dividend Channel Staff - Monday, September 18, 4:10 PM
Investors Pick Up ZNTL Even Cheaper Than Its Secondary Stock Offering
Dividend Channel Staff - Monday, September 18, 1:12 PM
Zentalis Pharmaceuticals (ZNTL) Shares Cross Below 200 DMA
Dividend Channel Staff - Monday, September 18, 11:36 AM
Analysts Anticipate 23% Upside For ESML
Dividend Channel Staff - Friday, September 8, 7:35 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares ESG Aware MSCI USA Small-Cap ETF (ESML), we found that the implied analyst target price for the ETF based upon its underlying holdings is $43.26 per unit. Read More »
Implied VBK Analyst Target Price: $270
Dividend Channel Staff - Tuesday, August 8, 10:47 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap Growth ETF (VBK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $269.70 per unit. Read More »
Commit To Purchase Zentalis Pharmaceuticals At $17.50, Earn 10.3% Annualized Using Options
Dividend Channel Staff - Monday, July 10, 1:40 PM
Sum Up The Parts: VBK Could Be Worth $263
Dividend Channel Staff - Wednesday, July 5, 6:19 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap Growth ETF (VBK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $262.65 per unit. Read More »
Analysts Expect VB Will Reach $224
Dividend Channel Staff - Wednesday, May 24, 6:44 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap ETF (VB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $224.34 per unit. Read More »
Notable Monday Option Activity: ZNTL, GOOG, MQ
Dividend Channel Staff - Monday, May 22, 3:32 PM
Thursday's ETF with Unusual Volume: IBBQ
Dividend Channel Staff - Thursday, July 8, 12:39 PM Read More »
|
A Brief Dividend History Top Dividends Opting for the Cash Dividend What is a Dividend? Dividend Calculator Dividend Yield Traps to Avoid Dividend Paying Stocks High Yield Stocks Paying Monthly Dividend Stocks: Their Importance Dividend ETFs High Dividend Stocks Paying Quarterly Dividend Aristocrats List Top Dividend Stocks YTD
Other news: News from PR Newswire |
|